Pituitary Tumour

A pituitary tumour can feel frightening, especially when words like “brain tumour,” “hormones,” or “surgery” appear in the same sentence. The reassuring reality is that most pituitary tumours are benign (non-cancerous), slow-growing, and respond well to modern treatment. At a specialised cancer centre with experienced endocrinologists, neurosurgeons, and radiation oncologists, most patients return to normal daily life with hormones under control and vision preserved. This coordinated, multidisciplinary approach is the foundation of good pituitary gland tumour care at Onco-Life Cancer Centre.

Understanding Pituitary Tumours: Types and Characteristics

The pituitary gland is a pea-sized “master gland” at the base of the brain, just behind the nose. It produces hormones that regulate the thyroid, adrenal glands, growth, reproduction, lactation, and more. When a pituitary gland tumour (most commonly a pituitary adenoma) develops, it can cause problems in two main ways:

By pressing on nearby structures, particularly the optic nerves and normal pituitary tissue.
By producing too much or too little hormone, leading to specific clinical syndromes.

Most pituitary tumours are benign adenomas. They are classified by size (micro or macro) and by whether they secrete hormones (functioning) or not (non-functioning). Identifying these features correctly is critical, because the treatment plan changes significantly depending on the type.

What Is a Pituitary Gland Tumour?

In simple terms, a pituitary tumour is an abnormal growth arising from cells of the pituitary gland.

Most pituitary tumours are adenomas, which are benign and do not spread.
They sit inside a bony cavity called the sella turcica at the base of the skull.
Even when benign, their position near the optic nerves and important brain structures means they can cause serious effects if not managed properly.

Because the pituitary gland acts as a hormone control centre, even a small disturbance in this area can create wide-reaching effects across the body.

Classifying Pituitary Adenomas: Size and Function

Doctors classify pituitary adenomas in two ways.

By Size

Microadenoma: Less than 10 mm in diameter. Often found incidentally on scans done for another reason.
Macroadenoma: 10 mm or larger. More likely to cause pressure effects such as headaches or visual problems.

By Hormonal Activity

Functioning pituitary adenoma: Produces excess amounts of one or more pituitary hormones.
- Prolactinoma: excess prolactin
- GH-secreting tumour: causes acromegaly
- ACTH-secreting tumour: causes Cushing’s disease
- TSH-secreting tumour: rare, causes hyperthyroidism
Non-functioning pituitary tumour: Does not secrete excess hormones. Symptoms arise mainly from mass effect, meaning pressure on the normal pituitary and nearby structures.

This basic classification guides the earliest decisions in treatment planning.

Pituitary Tumour Symptoms: Recognising the Signs

Pituitary tumour symptoms depend on three things: the tumour’s size, the direction in which it grows, and whether it produces hormones. Some small tumours cause no symptoms and are found by chance on an MRI done for another reason. Others present with sudden vision loss or severe headaches. Recognising these signs early is important, particularly if you already have hormonal issues or noticeable changes in vision.

Symptoms Caused by Tumour Size

Larger tumours (macroadenomas) can press on nearby structures, causing:

Headache: Dull, persistent, often felt behind the eyes or in the forehead.
Visual impairment: Loss of side (peripheral) vision (a pattern called bitemporal hemianopia), blurred or double vision, difficulty reading, or bumping into objects.
Pituitary apoplexy (emergency): Sudden severe headache, vomiting, visual loss, and sometimes confusion or collapse, caused by bleeding or sudden swelling inside the tumour. If you or someone you know develops these symptoms, seek emergency medical care immediately.
Hypopituitarism from compression: Fatigue, low blood pressure, loss of libido, menstrual changes, cold intolerance, or weight changes, due to reduced secretion of normal pituitary hormones.

Symptoms from Hormonal Imbalance

Functioning pituitary adenomas produce distinctive clinical pictures based on the hormone involved.

Prolactinoma (excess prolactin)

In women: irregular or absent periods, milk discharge from breasts without pregnancy, infertility, reduced libido.
In men: reduced libido, erectile dysfunction, infertility, occasional breast enlargement.

Growth hormone (GH)-secreting tumour, causing acromegaly

Enlarged hands, feet, jaw, and facial features
Coarser facial appearance, widening gaps between teeth
Snoring or sleep apnoea
Joint pain, excessive sweating, fatigue
Over time, high blood pressure, diabetes, and heart enlargement

ACTH-secreting tumour, causing Cushing’s disease

Weight gain around the trunk and face (“moon face”)
Fragile skin, easy bruising, purple stretch marks
Muscle weakness, fatigue, mood changes
High blood pressure, diabetes, higher infection risk

TSH-secreting tumour (rare)

Signs of an overactive thyroid despite a “normal” thyroid gland
Palpitations, anxiety, weight loss, tremors, heat intolerance

Hormone deficiency from tumour pressure

Low thyroid (TSH deficiency): tiredness, weight gain, feeling cold
Low cortisol (ACTH deficiency): weakness, low blood pressure, dizziness
Low LH or FSH: loss of periods, reduced libido, infertility
Low GH in adults: low energy, reduced muscle mass, increased body fat

Often, a combination of mass effect and hormonal change brings a patient to medical attention.

Causes and Risk Factors of Pituitary Tumours

For most people, the cause of a pituitary tumour is not known. The majority of adenomas are sporadic, meaning they occur by chance without a clear trigger. Some recognised risk factors include:

Certain inherited (genetic) syndromes
A family history of pituitary tumours
Rare gene mutations affecting pituitary cells

There is no strong evidence that lifestyle factors such as smoking or diet cause pituitary adenomas the way they contribute to other cancers, but maintaining overall vascular and neurological health is still worthwhile.

Genetic Syndromes Linked to Pituitary Tumours

A small but important group of pituitary tumours occur as part of hereditary syndromes:

MEN1 (Multiple Endocrine Neoplasia Type 1): Tumours in parathyroid, pancreatic islets, and pituitary. Often prolactin- or GH-secreting.
Carney complex: Skin pigment spots, heart myxomas, adrenal and pituitary tumours.
FIPA (Familial Isolated Pituitary Adenomas): Pituitary tumours in multiple family members without other endocrine tumours.
AIP mutation-associated tumours: Often larger, more aggressive GH-secreting adenomas in younger patients.

If a pituitary tumour is diagnosed in a young person, or there is a strong family history, genetic counselling and testing may be advised.

Comprehensive Pituitary Tumour Diagnosis at Onco-Life Cancer Centre

Accurate diagnosis requires both imaging and detailed hormonal testing. At Onco-Life Cancer Centre, evaluation is supervised jointly by endocrinologists, neurosurgeons, and radiologists, so no detail is missed.

A typical diagnostic work-up includes:

Clinical history and physical examination
Visual field testing, if there are visual symptoms or a macroadenoma
MRI of the pituitary
A comprehensive pituitary hormone panel

Advanced Imaging

MRI of the pituitary with gadolinium contrast is the gold standard test. It provides high-resolution images of the gland and surrounding structures, allowing precise measurement of tumour size, shape, and relation to the optic nerves.

Gadolinium-enhanced MRI highlights the tumour against normal tissue.
CT scan of the pituitary may be used when MRI is not possible, or to study bony anatomy before surgery.

Hormonal and Biochemical Testing

Pituitary hormone tests help classify the tumour and detect associated deficiencies:

Prolactin levels, for suspected prolactinoma or to rule out “stalk effect” hyperprolactinaemia
IGF-1 (Insulin-like Growth Factor-1), as a screen for GH excess (acromegaly)
Cortisol testing for Cushing’s disease or adrenal insufficiency: late-night salivary cortisol, 24-hour urinary free cortisol, low-dose dexamethasone suppression test, morning serum cortisol with ACTH
Thyroid function (TSH, Free T4), to detect TSH-secreting tumours or pituitary hypothyroidism
Gonadal hormones (LH, FSH, oestradiol, testosterone), to assess the reproductive axis
Other pituitary hormones such as GH, ACTH, and ADH, in selected cases

Results are interpreted in context. Medications, stress, pregnancy, and other illnesses can affect hormone levels, so experienced endocrine input is essential.

In some cases, advanced imaging such as a PET-CT scan may be advised to study tumour behaviour, rule out rare aggressive features, or assess complex cases. Patients can access PET-CT services across multiple Onco-Life centres in Maharashtra:

Pituitary Tumour Treatment Options

Modern pituitary tumour treatment is highly individualised. Some tumours can be managed almost entirely with medication. Others need surgery first. A few require a combination of surgery, medical therapy, and radiation. Specialised centres in India offer:

Endoscopic transsphenoidal neurosurgery
Medical therapy for functioning adenomas
Stereotactic radiosurgery and focused radiation when required

The goal is consistent: control or remove the tumour, restore hormone balance, protect vision, and preserve quality of life.

Transsphenoidal Surgery

For many macroadenomas and some functioning tumours, transsphenoidal surgery is the primary treatment.

Access is gained through the nose and sphenoid sinus, avoiding a large scalp incision.
Using a microscope or endoscope, the neurosurgeon removes as much of the tumour as safely possible.
Normal pituitary tissue and surrounding structures are preserved wherever feasible.

Benefits of modern pituitary surgery include a shorter hospital stay, quicker recovery, less discomfort, minimal visible scarring, and rapid relief of pressure-related symptoms such as headache and visual field defects in many patients. Not all tumours can be removed completely. If the tumour invades nearby structures or is very fibrous, a small remnant may be left and treated with medication or radiation.

Medical Therapy for Functioning Adenomas

For some tumours, especially functioning adenomas, medical therapy is central and may even be the first-line option.

Prolactinoma: Dopamine agonists such as cabergoline or bromocriptine lower prolactin levels, shrink the tumour in most patients, and often remove the need for surgery.

Acromegaly (GH-secreting): Somatostatin analogues such as octreotide or lanreotide suppress GH secretion and may shrink the tumour. GH receptor antagonists such as pegvisomant block GH action at target tissues. Dopamine agonists are used in selected cases. Medical therapy is also used after surgery if GH levels remain high.

Cushing’s disease (ACTH-secreting): Medicines that reduce cortisol production, block cortisol receptors, or, in specialist settings, act directly on the pituitary.

TSH-secreting and other rare tumours: Somatostatin analogues and other targeted agents.

Hormone replacement: When pituitary function is reduced (hypopituitarism), replacement of thyroid hormone, cortisol, sex hormones, and sometimes GH restores normal body function and helps prevent long-term complications.

Radiation Therapy

Radiation therapy is usually reserved for:

Residual tumour after surgery
Tumours not suitable for surgery
Tumours not fully controlled by medication

Options include stereotactic radiosurgery (Gamma Knife or CyberKnife), typically given in a single or limited number of sessions, and fractionated radiotherapy, with smaller doses over multiple sessions, used when the tumour is large or close to sensitive structures. The effects of radiation are gradual. Tumour control and hormone changes can take months to years, so long-term follow-up is essential.

Government Schemes and Insurance Support

Onco-Life Cancer Centre is empanelled under major government health schemes, which can reduce or eliminate the treatment cost for eligible patients:

Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY)
Ayushman Bharat (PM-JAY)
Central Government Health Scheme (CGHS)
GIPSA cashless insurance

Eligibility criteria apply. Please verify your eligibility before visiting. Check government scheme eligibility here.

Why Choose Onco-Life Cancer Centre for Pituitary Tumour Care?

At Onco-Life Cancer Centre, pituitary tumour care is built around three pillars: expertise, coordination, and compassion. Patients benefit from:

Evidence-based protocols for all major pituitary adenoma types
Close collaboration between endocrinology, neurosurgery, radiation oncology, and neuro-ophthalmology
A focus on long-term hormonal and quality-of-life outcomes, not just the MRI scan
Access to a NABH-accredited multidisciplinary cancer network across Maharashtra, including centres in Pune, Chiplun, Satara and Talegaon Dabhade

Our Multidisciplinary Team

A pituitary tumour patient at Onco-Life is typically cared for by:

Endocrinologists, who lead hormonal evaluation and long-term medical management, and fine-tune replacement therapy
Neurosurgeons, trained in endoscopic and microscopic transsphenoidal pituitary surgery
Radiation oncologists, who plan and deliver precise radiation when required
Neuro-ophthalmologists, who assess visual fields and optic nerve function before and after treatment
Radiologists, pathologists, and rehabilitation specialists, who support accurate diagnosis and recovery planning

Every major decision is discussed collectively, so no step is taken in isolation. Patients also benefit from consultations with senior cancer specialists as part of this multidisciplinary process.

Patient-Centred Care and Support

A pituitary tumour affects more than test results. It can influence mood, energy, body image, fertility, and relationships. Onco-Life places equal weight on:

Clear, honest explanations of the diagnosis and treatment choices
Counselling around fertility, pregnancy planning, work, and lifestyle
Psychological support for patients living with chronic hormonal issues or visible changes, for example in acromegaly or Cushing’s disease

This whole-person approach recognises that treating the gland is only one part of caring for the patient.

Prognosis and Life After Pituitary Tumour Treatment

The outlook for most benign pituitary adenomas is generally favourable, especially when diagnosed early and treated at a specialised centre. Depending on tumour type and stage, many patients:

Return to normal or near-normal daily life
Have stable MRI scans with no or minimal residual tumour
Achieve well-controlled hormone levels with or without ongoing medication

Long-term follow-up is essential. Even after successful surgery, patients may need periodic MRI scans, regular hormone testing with medication adjustments, and ongoing monitoring of vision and general health. Care continues well beyond the operation or radiation course.

Book a Consultation at Onco-Life Cancer Centre

If you have been told you have a pituitary lesion, or you recognise several of the symptoms described above, a specialised opinion is worthwhile. To book a consultation with a pituitary tumour specialist at Onco-Life, please Book a Doctor Appointment or request a Second Opinion from Our Oncologists. Our coordinators will connect you with the right team and guide you through the next steps.

Frequently Asked Questions

Pituitary Tumour-FAQs

Are All Pituitary Tumours Cancerous?

No. The vast majority are benign adenomas that do not spread. Rare malignant pituitary carcinomas exist but are exceptional. Any pituitary growth still needs specialist evaluation.

Is A Pituitary Tumour Curable?

Many benign adenomas are effectively controlled or removed with surgery, medication or radiation. Complete cure depends on tumour type, size and response to treatment.

Can Pituitary Tumours Be Shrunk Without Surgery?

Yes. Prolactinomas often shrink significantly with dopamine agonist tablets. Some GH- and TSH-secreting tumours also respond to targeted medication, though surgery may still be needed.

Can A Pituitary Tumour Affect Fertility?

Yes. Hormone disturbances can disrupt periods, ovulation, sperm production and libido. With appropriate treatment, fertility often improves and pregnancy planning becomes possible under specialist care.

What Are The Long-Term Effects Of Pituitary Tumour Surgery?

Most patients recover well. Possible issues include hormone deficiencies needing replacement, rare cerebrospinal fluid leak, or residual tumour requiring further treatment.

How Often Will I Need Follow-Up After Treatment?

Initially every 3 to 6 months with hormone tests and periodic MRI. Once stable, intervals may extend to yearly. The schedule is personalized to each patient.

Is Pituitary Tumour Treatment Covered Under Ayushman Bharat Or Mipjay At Onco-Life?

Onco-Life is empanelled under MJPJAY, PM-JAY (Ayushman Bharat) and CGHS. Coverage depends on eligibility and the specific treatment; please verify before visiting.